Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression

被引:0
|
作者
David Z Chang
Ying Ma
Baoan Ji
Yan Liu
Patrick Hwu
James L Abbruzzese
Craig Logsdon
Huamin Wang
机构
[1] The University of Texas MD Anderson Cancer Center,Departments of Gastrointestinal Medical Oncology
[2] The University of Texas MD Anderson Cancer Center,Immunology
[3] The University of Texas MD Anderson Cancer Center,Cancer Biology
[4] The University of Texas MD Anderson Cancer Center,Melanoma
[5] The University of Texas MD Anderson Cancer Center,Pathology
[6] Virginia Oncology Associates,undefined
关键词
CDC20; Pancreatic cancer; Tumorigenesis; Progression; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression
    Chang, David Z.
    Ma, Ying
    Ji, Baoan
    Liu, Yan
    Hwu, Patrick
    Abbruzzese, James L.
    Logsdon, Craig
    Wang, Huamin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [2] EXPRESSION OF CELL DIVISION CYCLE 20 HOMOLOG (CDC20) IS ASSOCIATED WITH TUMORIGENESIS AND PROGRESSION OF PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
    Li, K.
    Wang, H.
    Ji, B.
    Logsdon, C.
    Chang, D. Z.
    Ma, Y.
    PANCREAS, 2008, 37 (04) : 480 - 480
  • [3] Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma
    Li, Jia
    Gao, Jian-Zhi
    Du, Jing-Li
    Huang, Zhong-Xi
    Wei, Li-Xin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (04) : 1547 - 1555
  • [4] Diabetes Progression and Chronic Pancreatitis Are Associated With an Increased Risk for Pancreatic Ductal Adenocarcinoma
    Lew, Daniel
    Jeon, Christie
    Lin, Yu-chen
    Kim, Sungjin
    Pandol, Stephen
    Pisegna, Joseph
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S39 - S39
  • [5] The role of CDC20 in the progression of colorectal cancer
    Abualsaud, Nouran
    Gazzaz, Nada
    Alhamid, Amal
    Alenizy, Deemah
    Alrfaei, Bahauddeen M.
    Alshehri, Mana
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma
    Hartley, Christopher
    Rowan, Daniel
    Chen, Xiuxu
    Gomez-Arellano, Luisa
    West, Anna Marie
    Oshima, Kiyoko
    Mackinnon, Alexander Craig
    PRACTICAL LABORATORY MEDICINE, 2020, 21
  • [7] Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma
    Yamakawa, Kohei
    Koyanagi-Aoi, Michiyo
    Uehara, Keiichiro
    Masuda, Atsuhiro
    Yanagimoto, Hiroaki
    Toyama, Hirochika
    Fukumoto, Takumi
    Kodama, Yuzo
    Aoi, Takashi
    Irshad, Khushboo
    PLOS ONE, 2022, 17 (05):
  • [8] Increased Expression of HYAL1 in Pancreatic Ductal Adenocarcinoma
    Kohi, Shiro
    Sato, Norihiro
    Cheng, Xiao-Bo
    Koga, Atsuhiro
    Hirata, Keiji
    PANCREAS, 2016, 45 (10) : 1467 - 1473
  • [9] CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression
    Ding, Yiming
    Yu, Shuqing
    Bao, Zhaoshi
    Liu, Yanwei
    Liang, Tingyu
    JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (01) : 87 - 95
  • [10] CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression
    Yiming Ding
    Shuqing Yu
    Zhaoshi Bao
    Yanwei Liu
    Tingyu Liang
    Journal of Neuro-Oncology, 2017, 133 : 87 - 95